Overview: Specific IgE (Cat Dander) Antibody Rapid TestIntroduction: The Specific IgE (Cat Dander) Antibody Rapid Test is a diagnostic tool designed to detect IgE antibodies to cat dander in serum, whole blood, or saliva samples, facilitating the screening of cat allergies. Associated with allergic rhinitis or asthma, this immunologic disorder presents with sneezing, itching, and severe complications like anaphylaxis if untreated, particularly in individuals with pet exposure or atopic history. Per the 2023 American Academy of Allergy, Asthma & Immunology guidelines, the test employs immunochromatographic technology, delivering results within 15-20 minutes with reasonable sensitivity and specificity, making it a valuable tool for initial screening in allergology settings. This rapid diagnostic falls under allergology and targets individuals with respiratory or dermatologic symptoms, addressing the challenge of early detection to guide allergen avoidance or immunotherapy. With morbidity rates elevated due to underdiagnosis, the test supports public health efforts by enabling early identification, facilitating treatment, and reducing complications. Its multi-sample capability enhances its practicality.Other Names: Cat Dander IgE Rapid Test.FDA Status: FDA approved, CLIA certified for allergology, compliant with 2025 standards.Historical Milestone: Introduced in the 2000s by Thermo Fisher, this test advanced allergy marker detection, providing a rapid alternative to skin prick testing.Purpose: The test screens for Cat Dander IgE to guide allergy diagnosis, assess immune status, and inform treatment and prevention strategies.Test Parameters: Presence of Cat Dander IgE, detected with reasonable specificity to indicate allergic sensitization, typically detectable in serum, blood, or saliva at elevated levels during active allergy.Pretest Condition: No fasting required; patients should avoid food or drink for 30 minutes prior to collection to ensure sample integrity, and they should report sneezing, itching, or recent pet exposure.Specimen: Serum 2-5 mL, Whole Blood 2-5 mL, Saliva 1-2 mL, collected using sterile SST, EDTA tubes, or containers, transported within 24 hours to maintain sample viability.Sample Stability at Room Temperature: 24 hours with proper handling in a cool environment to preserve marker integrity, ensuring reliable test performance.Sample Stability at Refrigeration: 24 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.Sample Stability at Frozen: Not recommended, as freezing may degrade markers, increasing the risk of false negatives and compromising diagnostic accuracy.Medical History: Patients should provide details on sneezing, itching, asthma history, or prior allergies, as well as any family history of atopic disease or recent pet exposure.Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated allergy including anaphylaxis, benefits of early detection, and minimal discomfort from sample collection.Procedural Considerations: The test utilizes an immunochromatographic cassette requiring trained personnel to ensure sterile technique, avoid contamination, and interpret results within 15-20 minutes using provided positive and negative controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store test kits according to manufacturer specifications to ensure reliability.Factors Affecting Result Accuracy: Delays beyond 24 hours, improper storage conditions, cross-contamination with other samples, or recent antihistamine use can affect results. Correlation with skin testing or clinical evaluation is recommended to confirm findings.Clinical Significance: A positive result indicates possible cat allergy, necessitating further investigation like skin testing or allergology consultation. A negative result may require follow-up testing if symptoms persist, especially if sampled during non-exposure periods.Specialist Consultation: Allergists should be consulted for case management, treatment planning, and coordination with allergy management programs.Additional Supporting Tests: Skin prick test, total IgE, or spirometry for confirmation.Test Limitations: The test may produce false positives in cross-reactivity or false negatives in early sensitization, requiring a comprehensive diagnostic approach that includes clinical correlation.References: AAAAI Guidelines 2023, Journal of Allergy and Clinical Immunology 2024, Pathology 2025.